Genomic Valley Biotech Limited (BOM:539206)
27.34
-0.21 (-0.76%)
At close: Dec 3, 2025
Genomic Valley Biotech Revenue
Genomic Valley Biotech had revenue of 900.00K INR in the quarter ending September 30, 2025, a decrease of -56.10%. This brings the company's revenue in the last twelve months to 6.64M, up 66.18% year-over-year. In the fiscal year ending March 31, 2025, Genomic Valley Biotech had annual revenue of 8.44M with 411.25% growth.
Revenue (ttm)
6.64M
Revenue Growth
+66.18%
P/S Ratio
12.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
84.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 8.44M | 6.79M | 411.25% |
| Mar 31, 2024 | 1.65M | -25.57M | -93.94% |
| Mar 31, 2023 | 27.23M | 26.52M | 3,758.23% |
| Mar 31, 2022 | 705.64K | -1.38M | -66.09% |
| Mar 31, 2021 | 2.08M | -6.38M | -75.42% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 10.00T |
| Life Insurance Corporation of India | 9.14T |
| State Bank of India | 3.57T |
| Larsen & Toubro | 2.76T |
| HDFC Bank | 2.68T |
| Tata Consultancy Services | 2.58T |
| Bharti Airtel | 1.95T |
| ICICI Bank | 1.91T |